BofA/Merrill Lynch Downgrades Novartis (NVS) to Neutral
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $56.43 +0.32%
Rating Summary:
2 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
2 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Novartis (NYSE: NVS) from Buy to Neutral.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $55.42 yesterday.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $55.42 yesterday.
Create E-mail Alert Related Categories
DowngradesRelated Entities
Merrill Lynch, Bank of AmericaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
